Contract Wins and Moorfields Trial
11 Settembre 2009 - 9:21AM
UK Regulatory
TIDMCUS
RNS Number : 9042Y
CustomVis plc
11 September 2009
11 September 2009
CUSTOMVIS PLC
("CustomVis" or "the Group")
Contract Wins and
Commencement of Moorfields Eye Hospital trial
CustomVis (AIM: CUS), the leading developer, manufacturer and distributor of
solid state laser systems for the refractive surgical industry is pleased to
announce it has signed two new contracts.
The first contract is with a surgeon in Spain where regulatory approval for the
Pulzar Z1 has now been granted. A letter of credit for the full payment was
received by the Group on 10 September and installation is expected to take place
in October.
The second client, which was one of the Group's first customers to receive a
free Pulzar Z1 laser to conduct trials, has been providing important surgical
data over the past five years. A change of personnel at the clinic has allowed
CustomVis to negotiate a new contract with the surgeon.
CustomVis will be attending the 27th Congress of the European Society of
Cataract and Refractive Surgeons (ESCRS) between 12-16 September where Paul van
Saarloos, the CEO of CustomVis, will present two papers on the clinical results
of the Pulzar Z1 laser. At least two other papers are expected to be presented
by other surgeons on this topic. ESCRS is Europe's leading organisation for the
industry with over 4,000 members from 90 different countries. The Pulzar Z1
laser will also be exhibited to potential customers over the five day event.
The laser trial at Moorfields Eye Hospital in London, which was delayed over the
summer period due to staffing commitments, has now commenced and the Group
expects to update shareholders with the results from the initial trials when it
announces its annual results in early November.
-ends-
For further information, please contact:
+---------------------------------------+---------------------------------------+
| CustomVis plc | |
+---------------------------------------+---------------------------------------+
| Simon Carroll, Chairman | +61 419 304 906 |
| Paul van Saarloos, CEO | +61 410 497 456 |
+---------------------------------------+---------------------------------------+
| | |
+---------------------------------------+---------------------------------------+
| John East & Partners Limited, subsidiary of Merchant Securities PLC |
+-------------------------------------------------------------------------------+
| David Worlidge / Simon Clements | 020 7628 2200 |
+---------------------------------------+---------------------------------------+
| | |
+---------------------------------------+---------------------------------------+
| Leander PR | |
+---------------------------------------+---------------------------------------+
| Christian Taylor-Wilkinson | 07795 168 157 |
+---------------------------------------+---------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTZGGMLNMGGLZG
Grafico Azioni Customvis (LSE:CUS)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Customvis (LSE:CUS)
Storico
Da Set 2023 a Set 2024
Notizie in Tempo Reale relative a Customvis (Borsa di Londra): 0 articoli recenti
Più Customvis Articoli Notizie